It's Time for Effective and Affordable Therapies for Cardiac Amyloidosis: Lessons From Patisiran

J Cardiothorac Vasc Anesth. 2024 Jul;38(7):1457-1459. doi: 10.1053/j.jvca.2024.02.035. Epub 2024 Mar 7.

Authors

Tiffany M Williams¹, Reed Harvey¹, Matthew A Fischer¹, Jacques Neelankavil²

Affiliations

¹ Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
² Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. Electronic address: [email protected].

PMID: 38584048
DOI: 10.1053/j.jvca.2024.02.035

No abstract available

Publication types

Editorial

MeSH terms

Amyloidosis* / therapy
Cardiomyopathies / therapy
Humans
RNA, Small Interfering
Treatment Outcome

Substances

patisiran
RNA, Small Interfering